Skip to main content
. 2020 Jul 3;17(9):1480–1486. doi: 10.1016/j.hrthm.2020.07.001

Figure 3.

Figure 3

Schematic diagram of the recommendations for electrocardiographic (ECG) monitoring during (hydroxy)chloroquine prophylaxis. ∗Individuals at risk are defined as those with a known history of congenital or acquired long QT syndrome, structural heart disease, bradycardia, use of other QT-prolonging drugs, and conditions with an increased risk of electrolyte disorders (such as chronic diarrhea or chronic kidney disease). Symptom education for patients, ensuring awareness of potential arrhythmic symptoms (eg, dizziness, syncope, and palpitations). QTc = corrected QT.